239 related articles for article (PubMed ID: 23313638)
1. Total synthesis of bicyclic depsipeptides spiruchostatins C and D and investigation of their histone deacetylase inhibitory and antiproliferative activities.
Narita K; Fukui Y; Sano Y; Yamori T; Ito A; Yoshida M; Katoh T
Eur J Med Chem; 2013 Feb; 60():295-304. PubMed ID: 23313638
[TBL] [Abstract][Full Text] [Related]
2. Total synthesis of burkholdacs A and B and 5,6,20-tri-epi-burkholdac A: HDAC inhibition and antiproliferative activity.
Fukui Y; Narita K; Dan S; Yamori T; Ito A; Yoshida M; Katoh T
Eur J Med Chem; 2014 Apr; 76():301-13. PubMed ID: 24589486
[TBL] [Abstract][Full Text] [Related]
3. Total synthesis of the bicyclic depsipeptide HDAC inhibitors spiruchostatins A and B, 5''-epi-spiruchostatin B, FK228 (FR901228) and preliminary evaluation of their biological activity.
Narita K; Kikuchi T; Watanabe K; Takizawa T; Oguchi T; Kudo K; Matsuhara K; Abe H; Yamori T; Yoshida M; Katoh T
Chemistry; 2009 Oct; 15(42):11174-86. PubMed ID: 19760730
[TBL] [Abstract][Full Text] [Related]
4. Total Synthesis of Thailandepsin B, a Potent HDAC Inhibitor Isolated from a Microorganism.
Narita K; Katoh T
Chem Pharm Bull (Tokyo); 2016; 64(7):913-7. PubMed ID: 27373645
[TBL] [Abstract][Full Text] [Related]
5. The first biologically active synthetic analogues of FK228, the depsipeptide histone deacetylase inhibitor.
Yurek-George A; Cecil AR; Mo AH; Wen S; Rogers H; Habens F; Maeda S; Yoshida M; Packham G; Ganesan A
J Med Chem; 2007 Nov; 50(23):5720-6. PubMed ID: 17958342
[TBL] [Abstract][Full Text] [Related]
6. [Synthetic Study on Bicyclic Depsipeptides Containing an Intramolecular Disulfide Bond].
Narita K
Yakugaku Zasshi; 2022; 142(9):917-926. PubMed ID: 36047217
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of novel FK228 analogues as potential isoform selective HDAC inhibitors.
Narita K; Matsuhara K; Itoh J; Akiyama Y; Dan S; Yamori T; Ito A; Yoshida M; Katoh T
Eur J Med Chem; 2016 Oct; 121():592-609. PubMed ID: 27318982
[TBL] [Abstract][Full Text] [Related]
8. FK228 (depsipeptide): a HDAC inhibitor with pleiotropic antitumor activities.
Konstantinopoulos PA; Vandoros GP; Papavassiliou AG
Cancer Chemother Pharmacol; 2006 Nov; 58(5):711-5. PubMed ID: 16435156
[TBL] [Abstract][Full Text] [Related]
9. Total synthesis and molecular target of largazole, a histone deacetylase inhibitor.
Ying Y; Taori K; Kim H; Hong J; Luesch H
J Am Chem Soc; 2008 Jul; 130(26):8455-9. PubMed ID: 18507379
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and activity of largazole analogues with linker and macrocycle modification.
Ying Y; Liu Y; Byeon SR; Kim H; Luesch H; Hong J
Org Lett; 2008 Sep; 10(18):4021-4. PubMed ID: 18707106
[TBL] [Abstract][Full Text] [Related]
11. Total synthesis of largazole and analogues: HDAC inhibition, antiproliferative activity and metabolic stability.
Benelkebir H; Marie S; Hayden AL; Lyle J; Loadman PM; Crabb SJ; Packham G; Ganesan A
Bioorg Med Chem; 2011 Jun; 19(12):3650-8. PubMed ID: 21420302
[TBL] [Abstract][Full Text] [Related]
12. Discovery of class I histone deacetylase inhibitors based on romidpesin with promising selectivity for cancer cells.
Zhang K; Yao Y; Tu Z; Liao C; Wang Z; Qiu Y; Chen D; Hamilton DJ; Li Z; Jiang S
Future Med Chem; 2020 Feb; 12(4):311-323. PubMed ID: 31782319
[No Abstract] [Full Text] [Related]
13. Synthesis and biological evaluation of c7-demethyl largazole analogues.
Chen F; Gao AH; Li J; Nan FJ
ChemMedChem; 2009 Aug; 4(8):1269-72. PubMed ID: 19431162
[No Abstract] [Full Text] [Related]
14. Design, synthesis and preliminary bioactivity studies of 1,3,4-thiadiazole hydroxamic acid derivatives as novel histone deacetylase inhibitors.
Guan P; Sun F; Hou X; Wang F; Yi F; Xu W; Fang H
Bioorg Med Chem; 2012 Jun; 20(12):3865-72. PubMed ID: 22579621
[TBL] [Abstract][Full Text] [Related]
15. Amide-based derivatives of β-alanine hydroxamic acid as histone deacetylase inhibitors: attenuation of potency through resonance effects.
Liao V; Liu T; Codd R
Bioorg Med Chem Lett; 2012 Oct; 22(19):6200-4. PubMed ID: 22932316
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological characterization of the histone deacetylase inhibitor largazole and C7- modified analogues.
Souto JA; Vaz E; Lepore I; Pöppler AC; Franci G; Alvarez R; Altucci L; de Lera AR
J Med Chem; 2010 Jun; 53(12):4654-67. PubMed ID: 20491440
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group.
Chen PC; Patil V; Guerrant W; Green P; Oyelere AK
Bioorg Med Chem; 2008 May; 16(9):4839-53. PubMed ID: 18397827
[TBL] [Abstract][Full Text] [Related]
18. Largazole Analogues as Histone Deacetylase Inhibitors and Anticancer Agents: An Overview of Structure-Activity Relationships.
Poli G; Di Fabio R; Ferrante L; Summa V; Botta M
ChemMedChem; 2017 Dec; 12(23):1917-1926. PubMed ID: 29117473
[TBL] [Abstract][Full Text] [Related]
19. Efficient solid-phase synthesis of FK228 analogues as potent antitumoral agents.
Di Maro S; Pong RC; Hsieh JT; Ahn JM
J Med Chem; 2008 Nov; 51(21):6639-41. PubMed ID: 18839938
[TBL] [Abstract][Full Text] [Related]
20. Biochemical, biological and structural properties of romidepsin (FK228) and its analogs as novel HDAC/PI3K dual inhibitors.
Saijo K; Imamura J; Narita K; Oda A; Shimodaira H; Katoh T; Ishioka C
Cancer Sci; 2015 Feb; 106(2):208-15. PubMed ID: 25492515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
